Lornalyn Grace Tongco
Family · Corona, CANPI 1245769561
Payments from drug & device makers
Across 724 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- Lilly USA, LLC$2K
- AbbVie$2K
- Johnson & Johnson$1K
- GSK$1K
- UCB, Inc.$921
- plus $5K from 20 others
What the payments were for
- Consulting fees$2502%
- Travel & lodging$160%
- Food & beverage$15,62896%
- Education$3052%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 197 | $3,847 |
| Lilly USA, LLC | 66 | $2,130 |
| AbbVie | 103 | $2,051 |
| Johnson & Johnson(2 entities) | 46 | $1,448 |
| GSK | 61 | $1,120 |
| UCB, Inc. | 32 | $921 |
| Novartis | 44 | $861 |
| Pfizer | 38 | $781 |
| AstraZeneca(2 entities) | 32 | $684 |
| Radius Health, Inc. | 16 | $429 |
| Aurinia Pharma U.S., Inc. | 11 | $334 |
| E.r. Squibb & Sons, L.L.C. | 13 | $295 |
| Mallinckrodt Hospital Products Inc. | 16 | $260 |
| Boehringer Ingelheim | 10 | $235 |
| Organon | 10 | $177 |
| Janssen Scientific Affairs, LLC | 1 | $117 |
| Antares Pharma, Inc. | 13 | $112 |
| Fresenius Kabi USA, LLC | 4 | $98 |
| Sobi, Inc | 3 | $76 |
| Cardinal Health 110 LLC | 1 | $75 |
| Tonix Medicines, Inc. | 1 | $34 |
| Alvogen Inc | 2 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| CSL Behring | 1 | $26 |
| Celltrion USA Inc. | 1 | $14 |
| Sanofi | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,200 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $102,188 |
| Hydroxychloroquine Sulfate | 197 | $11,204 |
| MethotrexateMethotrexate Sodium | 121 | $3,858 |
| Leflunomide | 85 | $3,558 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $994 |
| Celecoxib | 44 | $909 |
| Duloxetine Hcl | 33 | $801 |
| Allopurinol | 59 | $735 |
| Colchicine | 12 | $718 |
| Diclofenac Sodium | 23 | $553 |
| Tramadol Hcl | 88 | $481 |
| Sulfasalazine | 14 | $441 |
| Prednisone | 85 | $408 |
| Gabapentin | 37 | $346 |
| Tizanidine Hcl | 46 | $303 |
Paid to pharmacies, not to this prescriber.
Other family in Corona
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.